You are running scared. You are assuming Baxter is responsible and no others share responsibilities for this contamination problem. IAs an investor, instead of continuing to look at teh glass half empty...look at the rest of teh glass. Baxter's whole picture and not just this $10 mil product has financials that look great. International sales and associated exchange value will continue to strengthen their revenue numbers. Baxter at this price is a steal ! That is why the strategic decision for the share buy back at these prices.
I agree. No deaths have been directly attributed to the heparin. People are getting a little ahead of themselves. As for the hospital part of the heparin, that is total BS. The hospital personnel have to read the labels..and if they can't there is a barcode that can be scanned on the unit that I am sure could be used for electronic verification.